ArticleEnvironmental toxicology2026
Chrysin Mitigates Acetamiprid-Induced Testicular Injury in Mice via Suppression of Endoplasmic Reticulum Stress and Inflammation.
Article in Environmental toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ameliorative Effects of Berberine Against Acetamiprid-Induced Toxicity in the Testes of Rats: A Computational and Histological Insight.Journal of xenobiotics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Acetamiprid (ACP) is a neonicotinoid pesticide that is extensively utilized for the management of insect populations, but its toxic effects on the male reproductive system have become a source of concern. Chrysin (CHR) is a natural flavone found in many plants and bee products, including honey and propolis. The objective of this study was to evaluate the protective effect of CHR on ACP-induced testicular injury in male Balb/c mice. ACP (20 mg/kg) and CHR applications (10 and 20 mg/kg, respectively) were conducted via intragastric route for a period of 14 days. The administration of CHR treatments resulted in a substantial improvement in oxidative stress and inflammation levels, achieved by the elimination of ACP's inhibition of the Nrf2 pathway. CHR treatments significantly reversed the ACP-induced depletion in serum testosterone and inhibin B levels. Specifically, the treatment of CHR at a dose of 20 mg/kg resulted in a substantial improvement in degenerative testicular findings induced by ACP, as indicated by a significant reduction in TUNEL (+) cell count. Furthermore, the provision of CHR treatments resulted in the cessation of the decline in sperm count and viability that had been induced by ACP, whilst concomitantly leading to a substantial reduction in the number of spermatozoa that exhibited severe abnormalities. These results suggest that CHR may have a protective effect against ACP-induced testicular damage; however, the results require further corroboration through the implementation of more comprehensive studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.